Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Organigram is increasing its investment in Phylos Bioscience, consolidating existing debt with a US$3 million advance, bringing the total loan principal to US$10 million.
Ultragenyx has completed the rolling submission of a Biologics License Application (BLA) to the U.S. FDA for DTX401 (pariglasgene brecaparvovec), a gene therapy for Glycogen Storage Disease Type Ia (GSDIa).
Brendan G. Carr, MD, MA, MS, CEO of Mount Sinai Health System, has been recognized as one of Modern Healthcare’s 100 Most Influential People in Healthcare.
Duos Edge AI, a subsidiary of Duos Technologies Group (DUOT), is expanding its Edge Data Center (EDC) deployments in Texas and entering the Illinois market (Greater Chicagoland Area).
Patrick NJ Schnegelsberg, CEO of Picard Medical and SynCardia Systems, has been elected to the Arizona Bioindustry Association (AZBio) Board of Directors.
Unlimited ETFs is transferring the listings of its HFMF Managed Futures ETF (HFMF) and HFEQ Equity Long/Short ETF (HFEQ) from NYSE Arca to the New York Stock Exchange (NYSE), effective January 2, 2026.
